Results 251 to 260 of about 2,868,112 (314)

Revisiting the standard of care for immune checkpoint inhibitors in early-stage triple-negative breast cancer: timing, duration, dose, combination, and patient selection. [PDF]

Front Immunol
Guo X, Li P, Wu W, Wang Y, Qiu J, Ma Q, Guo X, Liu K, Wang Y, Ruan W, Tao S, Xu Z, Shi Y, Zhou Y.   +13 more
europepmc   +1 more source

Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Endovascular treatment (EVT) achieves high rates of recanalization in acute large‐vessel occlusion (LVO) stroke, but functional recovery remains heterogeneous. While symptomatic intracranial hemorrhage (sICH) has been well studied, the prognostic impact of asymptomatic intracranial hemorrhage (aICH) after EVT is less certain ...
Shihai Yang, Chengsong Yue, Zhuang Li, Xiaolei Shi, Haoxuan Zhu, Jie Yang, Linyu Li, Jiaxing Song, Shitao Fan, Gaoming Li, Wenzhe Sun, Zhixian Ye, Jiacheng Huang, Dahong Yang, Jinfu Ma, Xu Xu, Zhixi Wang, Lilan Wang, Guojian Liu, Fengli Li, Changwei Guo, Li Qi, Wenjie Zi   +22 more
wiley   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma. [PDF]

Blood Cancer J
Kumar S, Jagannath S, Weisel KC, Rosiñol L, Leleu X, Dimopoulos MA, Kastritis E, Siegel DS, Monge J, Du J, de la Rubia J, Asensi Cantó P, Lee JH, Mateos MV, Puertas B, Gozzetti A, Dytfeld D, Ocio EM, Blade J, Ozaki S, Beksac M, Escalante F, Nagaraj M, Hassan R, Bonar N, Spin P, Shokoohi M, Siddiqui M, Wang D, Hou K, West MED, Hampp C, Green J, Humblet O, Breskin A, Harnett J, Ge W, Sobel RE, Jalbert JJ, Kroog GS, Rodriguez Lorenc K, Ma Q, Durie BGM.   +42 more
europepmc   +1 more source

Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Accessing brain magnetic resonance imaging (MRI) can be challenging, especially for underserved patients, which may lead to disparities in neurological diagnosis. Method This mixed‐methods study enrolled adults with one of four neurological disorders: mild cognitive impairment or dementia of the Alzheimer type, multiple sclerosis ...
Maya L. Mastick, Nomin Enkhtsetseg, Joseph Sadok, Matheus Mochetti, Annabel Sorby Adams, Jennifer Guo, Cristina Trapaga Hacker, Isabella Gomez Hjerthen, Seungwon Lee, Siddharth Satish, Andrew S. Ham, Justin Hill, Denis Balaban, Kevin Kyle, Rebecca L. Gillani, Marcelo Matiello, Aleksandar Videnovic, Eric C. Klawiter, W. Taylor Kimberly, Farrah J. Mateen   +19 more
wiley   +1 more source

Methylprednisolone plus MTX-based regime vs prednisone-based standard of care for GCA: a propensity score study. [PDF]

Rheumatology (Oxford)
Soto-Peleteiro A, Hernández-Rodríguez J, Raad F, de Miguel B, Acha L, Torio M, Hernandez-Negrin H, Gómez-Caverzaschi V, Ruiz-Arruza I, Araujo O, Prieto-González S, Espígol-Frigolé G, Cid MC, Ruiz-Irastorza G.   +13 more
europepmc   +1 more source

Strengthening the standard of care for perinatal substance use disorders: reproductive health provider perspectives on training, integration, and system improvements. [PDF]

Subst Abuse Treat Prev Policy
Holcomb LA, Shealy B, Eichelberger K, Cartmell K, Mayo R.   +4 more
europepmc   +1 more source

Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging Treatment. [PDF]

Int J Mol Sci
Cicchetti R, Basconi M, Litterio G, Orsini A, Mascitti M, Digiacomo A, Salzano G, Tătaru OS, Ferro M, Giulioni C, Cafarelli A, Schips L, Marchioni M.   +12 more
europepmc   +1 more source

Standard-of-care vs expert-recommended discharge destinations for geriatric surgical inpatients: a prospective observational cohort study. [PDF]

Eur Geriatr Med
Leinert C, Brefka S, Fotteler ML, Mueller-Stierlin AS, Gebhard F, Rahbari N, Bolenz C, Kestler H, Dallmeier D, Denkinger M, Kocar TD.   +10 more
europepmc   +1 more source

Life Years Gained and Healthcare Dollars Saved: National Economic Evidence Supporting Comprehensive Genomic Profiling as Standard of Care for Canadian Cancer Patients. [PDF]

Curr Oncol
Snow S, Banerji S, Bombard Y, Husereau D, Karamchandani J, Nason E, Ohashi PS, van Rooijen G, Vainer G, Macaulay C, Servidio-Italiano F.   +10 more
europepmc   +1 more source